These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24781046)

  • 1. Na(+)/K(+)-ATPase inhibition by cisplatin and consequences for cisplatin nephrotoxicity.
    Kubala M; Geleticova J; Huliciak M; Zatloukalova M; Vacek J; Sebela M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):194-200. PubMed ID: 24781046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part.
    Huličiak M; Vacek J; Sebela M; Orolinová E; Znaleziona J; Havlíková M; Kubala M
    Biochem Pharmacol; 2012 Jun; 83(11):1507-13. PubMed ID: 22394404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na
    Šeflová J; Čechová P; Štenclová T; Šebela M; Kubala M
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):701-706. PubMed ID: 29577756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystals of Na(+)/K(+)-ATPase with bound cisplatin.
    Huliciak M; Reinhard L; Laursen M; Fedosova N; Nissen P; Kubala M
    Biochem Pharmacol; 2014 Dec; 92(3):494-8. PubMed ID: 25199459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Na
    Šeflová J; Čechová P; Biler M; Hradil P; Kubala M
    Biochimie; 2017 Jul; 138():56-61. PubMed ID: 28435145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid.
    Nechay BR; Neldon SL
    Cancer Treat Rep; 1984 Sep; 68(9):1135-41. PubMed ID: 6148141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cells.
    Sakakibara N; Suzuki K; Kaneta H; Yoshimura Y; Deyama Y; Matsumoto A; Fukuda H
    Anticancer Drugs; 1999 Feb; 10(2):203-11. PubMed ID: 10211551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polygodial and its direct derivatives on the mammalian Na
    Garcia DG; Gonçalves-de-Albuquerque CF; da Silva CI; Kiss R; Dasari R; Chandra S; Kornienko A; Burth P
    Eur J Pharmacol; 2018 Jul; 831():1-8. PubMed ID: 29715454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na
    Svrckova M; Zatloukalova M; Dvorakova P; Coufalova D; Novak D; Hernychova L; Vacek J
    Free Radic Biol Med; 2017 Jul; 108():146-154. PubMed ID: 28342847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin.
    Eljack ND; Ma HY; Drucker J; Shen C; Hambley TW; New EJ; Friedrich T; Clarke RJ
    Metallomics; 2014 Nov; 6(11):2126-33. PubMed ID: 25306996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mercury binding site on Na+/K(+)-ATPase: a cysteine in the first transmembrane segment.
    Wang X; Horisberger JD
    Mol Pharmacol; 1996 Sep; 50(3):687-91. PubMed ID: 8794911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma subunit of Na+, K+-ATPase: role on ATPase activity and regulatory phosphorylation by PKA.
    Cortes VF; Veiga-Lopes FE; Barrabin H; Alves-Ferreira M; Fontes CF
    Int J Biochem Cell Biol; 2006; 38(11):1901-13. PubMed ID: 16815075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
    Hauck C; Frishman WH
    Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and recovery of (mu(3)-diethylentriamino)-chloro-palladium(II)-chloride induced inhibition of Na/K-ATPase by SH containing ligands--L-cysteine and glutathione.
    Krinulović K; Bugarcić Z; Vrvić M; Krstić D; Vasić V
    Toxicol In Vitro; 2006 Dec; 20(8):1292-9. PubMed ID: 16697549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
    Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonolignans As a Novel Class of Sodium Pump Inhibitors.
    Kubala M; Čechová P; Geletičová J; Biler M; Štenclová T; Trouillas P; Biedermann D
    Front Physiol; 2016; 7():115. PubMed ID: 27065883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the alterations of Na(+), K(+)-ATPase following ischaemia-reperfusion injury in the rat kidney.
    Fekete A; Vannay A; Vér A; Vásárhelyi B; Müller V; Ouyang N; Reusz G; Tulassay T; Szabó AJ
    J Physiol; 2004 Mar; 555(Pt 2):471-80. PubMed ID: 14673189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cisplatin on renal ATPase activity in vivo and in vitro.
    Uozumi J; Litterst CL
    Cancer Chemother Pharmacol; 1985; 15(2):93-6. PubMed ID: 2990752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of salinity acclimation on Na(+)/K(+)-ATPase responses and FXYD11 expression in the gills and kidneys of the Japanese eel (Anguilla japonica).
    Tang CH; Lai DY; Lee TH
    Comp Biochem Physiol A Mol Integr Physiol; 2012 Nov; 163(3-4):302-10. PubMed ID: 22885345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Phe788 --> Leu of the Na+,K+-ATPase is inhibited by micromolar concentrations of potassium and exhibits high Na+-ATPase activity at low sodium concentrations.
    Vilsen B
    Biochemistry; 1999 Aug; 38(35):11389-400. PubMed ID: 10471289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.